Clinical Trial: Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2

U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263776) titled 'Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2' on Nov. 23.

Brief Summary: This study is a randomized, double-blind, placebo-controlled clinical trial. We aim to assess the efficacy and safety of interleukin-6 receptor inhibitor combined with endovascular treatment in patients with acute anterior circulation large vessel occlusion stroke.

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: Tocilizumab

240 mg of tocilizumab injection will be diluted in 0...